PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $106,000 | -27.4% | 15,091 | +0.7% | 0.00% | -100.0% |
Q1 2021 | $146,000 | -54.2% | 14,983 | -52.6% | 0.00% | -50.0% |
Q3 2020 | $319,000 | +63.6% | 31,616 | +37.0% | 0.00% | 0.0% |
Q1 2020 | $195,000 | -82.4% | 23,082 | -77.6% | 0.00% | -77.8% |
Q3 2019 | $1,107,000 | +427.1% | 102,825 | +1803.5% | 0.01% | +350.0% |
Q1 2019 | $210,000 | +98.1% | 5,402 | +202.6% | 0.00% | +100.0% |
Q2 2018 | $106,000 | -83.0% | 1,785 | -80.5% | 0.00% | -80.0% |
Q1 2018 | $624,000 | +0.8% | 9,165 | +46.5% | 0.01% | -16.7% |
Q4 2017 | $619,000 | +96.5% | 6,258 | +137.6% | 0.01% | +100.0% |
Q3 2017 | $315,000 | +22.6% | 2,634 | -31.3% | 0.00% | 0.0% |
Q3 2016 | $257,000 | +43.6% | 3,834 | +61.2% | 0.00% | +200.0% |
Q3 2015 | $179,000 | -75.4% | 2,378 | -61.8% | 0.00% | -80.0% |
Q2 2015 | $728,000 | +73.3% | 6,233 | +181.1% | 0.01% | +150.0% |
Q4 2014 | $420,000 | +268.4% | 2,217 | +364.8% | 0.00% | +100.0% |
Q3 2014 | $114,000 | -50.2% | 477 | -88.8% | 0.00% | 0.0% |
Q3 2013 | $229,000 | – | 4,270 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |